Target intelligence / Profile preview

RNA, U6 small nuclear 1167, pseudogene (RNU6-1167P)

Target
RNU6-1167P
Molecular classification
Other, Pseudogene, Small nuclear RNA pseudogene
01

Overview

RNU6-1167P is a pseudogene annotated as "RNA, U6 small nuclear 1167, pseudogene." Pseudogenes are genomic sequences similar to known genes but are nonfunctional due to mutations or truncation. The parental functional gene here is the U6 small nuclear RNA gene, which encodes U6 snRNA, a crucial RNA component of the spliceosome involved in pre-mRNA splicing[1][2][3]. However, RNU6-1167P does not encode a functional snRNA and does not participate in canonical biological processes such as splicing. It is one of many pseudogenes in the human genome derived from retrotransposition events involving the U6 snRNA, and its presence marks past genetic activity but does not have an active or therapeutic molecular role[2][4]. No; pseudogenes like RNU6-1167P are generally not considered therapeutic targets, receptors, enzymes, transporters, or entities involved in disease processes or drug interactions[2][4]. There is no evidence for biological activity or disease relevance of RNU6-1167P, nor are there known drugs, biomarkers, mechanisms, or safety concerns associated with it. Yes; "RNU6-1167P" is not a target in the conventional sense (receptor, enzyme, transporter, etc.), but a noncoding pseudogene. Queries about its role as a therapeutic target or receptor are therefore incorrect or misleading[2][4]. RNU6-1167P is a nonfunctional pseudogene related to the U6 snRNA gene, with no known biological, therapeutic, or diagnostic significance and should not be confused with functional targets or receptors[2][4].

Other names
RNU6-1167PRNA, U6 small nuclear 1167, pseudogene

Beyond the preview

Go deeper on RNA, U6 small nuclear 1167, pseudogene (RNU6-1167P).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on RNA, U6 small nuclear 1167, pseudogene (RNU6-1167P).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call